AbbVie Wins Approval of Hepatitis C Treatment by Unknown Author

By Unknown Author

Insurers are hoping that a new competitor to Gilead Sciences’ drugs for the disease will drive down prices.

Published: December 20, 2014 at 12:00AM

from NYT Business Day http://ift.tt/1CeuIY6

from WordPress http://ift.tt/1wuTXVL

via Hadi Aboukhater